CUREMARK
Company Overview
Social Media Profiles
About Curemark
Description
Curemark is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies targeting neurological and other disorders. Through rigorous research and development, Curemark aims to address unmet medical needs and improve the quality of life for patients through advanced biotechnology solutions.
Specialties
Innovative autism therapies
Neurological disorder treatments
Disorder-modifying drug development
Clinical-stage biopharmaceutical research
Neuro-developmental and neurodegenerative focus
Products & Services
CM-AT for Autism
Neurological Therapies
Neurodevelopmental Disorder Treatments
Neurodegenerative Disorder Solutions
Biotechnology Research Services
Contact Information
Email Addresses
Competitors & Similar Companies(9)
Acorda Therapeutics
New York, • United States
Neurocrine Biosciences
California, • United States
Intra-Cellular Therapies
New York, • United States
Zymeworks
British Columbia, • Canada
Sage Therapeutics
Massachusetts, • United States
Axovant Gene Therapies
Basel-City, • Switzerland
Alkermes
Dublin, • Ireland
Neurotrope
Ovid Therapeutics
New York, • United States
News & Media
Search Terms:
curemark
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Frequently Asked Questions about Curemark
Where is Curemark located?
The headquarter of Curemark is located in Rye, New York, United States
What is the email address of Curemark?
The email addresses of Curemark are [email protected]
What is the official website of Curemark?
The official website of Curemark is https://www.curemark.com
What industry does Curemark belong to?
Curemark belongs to the Biotechnology, Biotechnology and Life Sciences industry.
What are the specialties of Curemark?
Curemark specializes in Innovative autism therapies, Neurological disorder treatments, Disorder-modifying drug development, Clinical-stage biopharmaceutical research, Neuro-developmental and neurodegenerative focus.
What products and services is Curemark likely to offer?
Curemark offers CM-AT for Autism, Neurological Therapies, Neurodevelopmental Disorder Treatments, Neurodegenerative Disorder Solutions, Biotechnology Research Services.
Who are the competitors of Curemark?
Competitors of Curemark are Acorda Therapeutics, Neurocrine Biosciences, Intra-Cellular Therapies, Zymeworks, Sage Therapeutics, Axovant Gene Therapies, Alkermes, Neurotrope, Ovid Therapeutics.
What does Curemark do?
Curemark is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies targeting neurological and other disorders. Through rigorous research and development, Curemark aims to address unmet medical needs and improve the quality of life for patients through advanced biotechnology solutions.